SEC Form 4 · accession 0001759655-26-000053
Privia Health Group, Inc. · PRVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Shawn Morris
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 4:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001759655
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per share | Jun 30, 2026 | M | 52,823 | $2.00 | A | 129,474 | D | |
| Common Stock, par value $0.01 per shareF2 | Jun 30, 2026 | S | 52,823 | $25.72 | D | 76,651 | D | |
| Common Stock, par value $0.01 per share | Jul 1, 2026 | M | 82,675 | $2.00 | A | 159,326 | D | |
| Common Stock, par value $0.01 per shareF3 | Jul 1, 2026 | S | 45,634 | $26.52 | D | 113,692 | D | |
| Common Stock, par value $0.01 per shareF4 | Jul 1, 2026 | S | 37,041 | $26.93 | D | 76,651 | D | |
| Common Stock, par value $0.01 per share | holding | — | — | — | 11,998 | I | By Trust | |
| Common Stock, par value $0.01 per share | holding | — | — | — | 12,487 | I | By Emerald Family, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F5 | $2.00 | Jun 30, 2026 | M | 52,823 | D | — | Aug 27, 2033 | Common Stock, par value $0.01 per share | 52,823 | 3,470,056 | D |
| Stock Option (Right to Purchase)F5 | $2.00 | Jul 1, 2026 | M | 82,675 | D | — | Aug 27, 2033 | Common Stock, par value $0.01 per share | 82,675 | 3,387,381 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.15 to $26.03 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.81 to $26.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.81 to $27.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F5All of the stock options are fully vested and exercisable.